Cargando…

Osteoclast regulation of osteoblasts via RANK-RANKL reverse signal transduction in vitro

The treatment of osteoporosis typically inhibits the activity of osteoclasts, which subsequently results in the suppression of bone formation and maintenance, however the underlying mechanism remains to be elucidated. The receptor activator of nuclear factor κ-B ligand (RANKL)-receptor activator of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Shiqian, Wang, Xiaoyu, Li, Guojun, Chong, Yang, Zhang, Jie, Guo, Xinzhen, Li, Baoxin, Bi, Zhenggang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5646979/ https://www.ncbi.nlm.nih.gov/pubmed/28731168 http://dx.doi.org/10.3892/mmr.2017.7039

Ejemplares similares

RANKL-RANK signaling regulates osteoblast differentiation and bone formation
por: Cao, Xu
Publicado: (2018)

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
por: Liu, Fei-Lan, et al.
Publicado: (2017)

Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK
por: Hu, Lijuan, et al.
Publicado: (2010)

Anoctamin 1 controls bone resorption by coupling Cl(−) channel activation with RANKL-RANK signaling transduction
por: Sun, Weijia, et al.
Publicado: (2022)

Osteocytes, not Osteoblasts or Lining Cells, are the Main Source of the RANKL Required for Osteoclast Formation in Remodeling Bone
por: Xiong, Jinhu, et al.
Publicado: (2015)

PKC-δ deficiency in B cells displays osteopenia accompanied with upregulation of RANKL expression and osteoclast–osteoblast uncoupling
por: Li, Shangfu, et al.
Publicado: (2020)

Functional Activation of Osteoclast Commitment in Chronic Lymphocytic Leukaemia: a Possible Role for RANK/RANKL Pathway
por: Marini, Cecilia, et al.
Publicado: (2017)

Lrp1 in osteoblasts controls osteoclast activity and protects against osteoporosis by limiting PDGF–RANKL signaling
por: Bartelt, Alexander, et al.
Publicado: (2018)

RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro
por: Sutherland, Karen A, et al.
Publicado: (2009)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

RANK–RANKL signalling in cancer
por: Renema, Nathalie, et al.
Publicado: (2016)

Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride
por: Chen, Zhang, et al.
Publicado: (2022)

Tumor Necrosis Factor α Stimulates Osteoclast Differentiation by a Mechanism Independent of the Odf/Rankl–Rank Interaction
por: Kobayashi, Kanichiro, et al.
Publicado: (2000)

Geranylgeraniol Application in Human Osteoblasts and Osteoclasts for Reversal of the Effect of Bisphosphonates
por: Jung, Junho, et al.
Publicado: (2023)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
por: Jansen, Ineke D.C., et al.
Publicado: (2020)

Quantitation of the Rank-Rankl Axis in Primary Biliary Cholangitis
por: Lleo, Ana, et al.
Publicado: (2016)

MicroRNA-503 Acts as a Tumor Suppressor in Osteosarcoma by Targeting L1CAM
por: Chong, Yang, et al.
Publicado: (2014)

Mesenchymal stem cells inhibit RANK-RANKL interactions between osteoclasts and Th17 cells via osteoprotegerin activity
por: Cho, Kyung-Ah, et al.
Publicado: (2017)

Case Report: A Case of Gallbladder Carcinosarcoma With Osteoclast-like Multinucleated Giant Cells that Was Associated With RANK‐RANKL Signaling
por: Niwa, Ayumi, et al.
Publicado: (2022)

RANK/RANKL expression in prostate cancer
por: Ohtaka, Mari, et al.
Publicado: (2016)

The Roadmap of RANKL/RANK Pathway in Cancer
por: Casimiro, Sandra, et al.
Publicado: (2021)

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes
por: Kondegowda, Nagesha Guthalu, et al.
Publicado: (2023)

Bisphosphonates Reduce Smoking-Induced Osteoporotic-Like Alterations by Regulating RANKL/OPG in an Osteoblast and Osteoclast Co-Culture Model
por: Zhu, Sheng, et al.
Publicado: (2020)

Targeting the RANKL/RANK/OPG Axis for Cancer Therapy
por: Ming, Jie, et al.
Publicado: (2020)

Melittin inhibits osteoclast formation through the downregulation of the RANKL-RANK signaling pathway and the inhibition of interleukin-1β in murine macrophages
por: Choe, Jung-Yoon, et al.
Publicado: (2017)

IL-15 deficiency alleviates steroid-induced osteonecrosis of the femoral head by impact osteoclasts via RANKL-RANK-OPG system
por: Zhou, Zubin, et al.
Publicado: (2020)

Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK
por: Evans, CE, et al.
Publicado: (2006)

ERK Inhibition Increases RANKL-Induced Osteoclast Differentiation in RAW 264.7 Cells by Stimulating AMPK Activation and RANK Expression and Inhibiting Anti-Osteoclastogenic Factor Expression
por: Choi, Eun-Bi, et al.
Publicado: (2022)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

RANK/RANKL/OPG system in the intervertebral disc
por: Takegami, Norihiko, et al.
Publicado: (2017)

Ghrelin is an Osteoblast Mitogen and Increases Osteoclastic Bone Resorption In Vitro
por: Costa, Jessica L., et al.
Publicado: (2011)

Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro
por: Yu, Su-Bin, et al.
Publicado: (2018)

The Role of miR-21 in Osteoblasts–Osteoclasts Coupling In Vitro
por: Smieszek, Agnieszka, et al.
Publicado: (2020)

Effect of amorphous silica nanoparticles on in vitro RANKL-induced osteoclast differentiation in murine macrophages
por: Nabeshi, Hiromi, et al.
Publicado: (2011)

RANKL neutralisation prevents osteoclast activation in a human in vitro ameloblastoma-bone model
por: Pape, Judith, et al.
Publicado: (2022)

Signaling crosstalk between RANKL and interferons in osteoclast differentiation
por: Takayanagi, Hiroshi, et al.
Publicado: (2002)

RANKL/RANK promotes the migration of gastric cancer cells by interacting with EGFR
por: Wan, Xing, et al.
Publicado: (2020)

Identification of a binding site on soluble RANKL that can be targeted to inhibit soluble RANK-RANKL interactions and treat osteoporosis
por: Huang, Dane, et al.
Publicado: (2022)

Effect of zinc substitution in hydroxyapatite coating on osteoblast and osteoclast differentiation under osteoblast/osteoclast co-culture
por: Meng, Guolong, et al.
Publicado: (2019)

ELMO1 Regulates RANKL-Stimulated Differentiation and Bone Resorption of Osteoclasts
por: Liang, Xinyue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_talctuc99visjdufdkft9221hu